Alnylam Pharmaceuticals Inc’s recently made public that its Chief Executive Officer Greenstreet Yvonne unloaded Company’s shares for reported $1.85 million on Jul 11 ’24. In the deal valued at $261.00 per share,7,093 shares were sold. As a result of this transaction, Greenstreet Yvonne now holds 73,441 shares worth roughly $17.17 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SCHULMAN AMY W sold 8,500 shares, generating $2,040,000 in total proceeds. Upon selling the shares at $240.00, the Director now owns 8,436 shares.
Before that, Greenstreet Yvonne sold 8,301 shares. Alnylam Pharmaceuticals Inc shares valued at $1,917,475 were divested by the Chief Executive Officer at a price of $230.99 per share. As a result of the transaction, Greenstreet Yvonne now holds 80,534 shares, worth roughly $18.83 million.
Goldman downgraded its Alnylam Pharmaceuticals Inc [ALNY] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”a Peer perform”‘ rating. Wells Fargo began covering ALNY with “an Equal weight” recommendation on December 08, 2023. Wells Fargo started covering the stock on December 08, 2023. It rated ALNY as “an Equal weight”.
Price Performance Review of ALNY
On Tuesday, Alnylam Pharmaceuticals Inc [NASDAQ:ALNY] saw its stock fall -1.05% to $233.81. Over the last five days, the stock has lost -0.20%. Alnylam Pharmaceuticals Inc shares have risen nearly 22.15% since the year began. Nevertheless, the stocks have risen 19.98% over the past one year. While a 52-week high of $263.73 was reached on 07/12/24, a 52-week low of $141.98 was recorded on 04/25/24. SMA at 50 days reached $200.37, while 200 days put it at $173.10. A total of 0.53 million shares were traded, compared to the trading of 0.46 million shares in the previous session.
Levels Of Support And Resistance For ALNY Stock
The 24-hour chart illustrates a support level at 231.30, which if violated will result in even more drops to 228.80. On the upside, there is a resistance level at 237.21. A further resistance level may holdings at 240.61. The Relative Strength Index (RSI) on the 14-day chart is 55.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -7.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.44%. Stochastics%K at 12.12% indicates the stock is a buying.
